$DV Cashflow Statement | Understand Stock

$DV

$13.54 -$0.01 (0.07%) Close

$DV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities
Bad debt expense
Depreciation and amortization expense
Amortization of debt issuance costs
Non-cash lease expense
Deferred taxes
Noncash stock-based compensation expense
Stock-based compensation expense
Interest expense, net
Loss on disposal of fixed assets
Impairment of long-lived assets
Change in fair value of contingent consideration
Offering costs
Other

Changes in operating assets and liabilities, net of effects of business combinations
Trade receivables
Prepaid expenses and other assets
Other non-current assets
Trade payables
Accrued expenses
Other current liabilities
Other non-current liabilities
Accrued expenses and other liabilities
Net cash provided by operating activities

Investing activities:
Purchase of property, plant and equipment
Acquisition of businesses, net of cash acquired
Purchase of short-term investments
Proceeds from maturity of short-term investments
Other investing activities
Net cash used in investing activities
Financing activities:
Payments of long-term debt
Proceeds from revolving credit facility
Payments to revolving credit facility
Payment of contingent consideration related to Zentrick acquisition
Proceeds from common stock issued upon exercise of stock options
Proceeds from common stock issued under employee purchase plan
Proceeds from issuance of common stock upon initial public offering
Proceeds from issuance of common stock in connection to concurrent private placement
Payments related to offering costs
Capital lease payments
Finance lease payments
Shares repurchased under the Repurchase Program and New Repurchase Program
Payment of excise tax on shares repurchased
Shares repurchased for settlement of employee tax withholdings
Net cash (used in) provided by financing activities
Deferred payment related to acquisition of assets
Zentrick NV acquisition
Zentrick
Total deferred payment related to acquisition of assets

Effect of exchange rate changes on cash and cash equivalents and restricted cash
Net (decrease) increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash - Beginning of period
Cash, cash equivalents, and restricted cash - End of period
Supplemental cash flow information:
Cash paid for taxes
Cash paid for interest
Noncash investing and financing transactions:
Right-of-use assets obtained in exchange for new operating lease liabilities, net of impairments and tenant improvement allowances
Acquisition of equipment under finance lease
Capital assets financed by accounts payable and accrued expenses
Stock-based compensation included in capitalized software development costs
Accrued excise tax on net share repurchases
Common stock issued in connection with acquisition
Liabilities for contingent consideration
Treasury stock reissued upon the conversion of Series A preferred stock for common stock
Offering costs included in accounts payable and accrued expense

Comments